GENE(Delisted)
Genetic TechnologiesยทNASDAQ
--
--(--)
GENE Profile
Genetic Technologies Limited
A global leader in genomics-based tests in health, wellness, and serious disease
--
01/05/1987
09/02/2005
NASDAQ Stock Exchange
60
06-30
Depository Receipts (Ordinary Shares)
60-66 Hanover Street, Fitzroy, Victoria, 3065, Australia
Genetic risk test
Genetic Technologies Limited was incorporated under the laws of Western Australia on 5 January 1987 as Concord Mining N.L. The company is a molecular diagnostic company that provides predictive testing and assessment tools to help physicians proactively manage people's health. The company's traditional product, BREVAGenplus, is a clinically proven non-hereditary breast cancer risk assessment test, the first of its kind. BREVAGenplus improves the predictive power of the first-generation BREVAGen test, designed to facilitate more informed decisions about breast cancer screening and preventive treatment plans.
